October 3, 2008
By:
Stanley Wulf
To be effective, an adherence strategy must be responsive to an array of patients with different habits and medications, while providing information, encouragement, and support until adherence becomes reliable.
|
October 15, 2007
By:
Tim Kelly
With Exprience and A new means of measuring impact on patient behavior, branders have never been in a better position to make their strategies work
|
October 15, 2007
By:
Scott Reese
Build it and they will come. But how do you make them stay?
|
October 15, 2007
By:
Richard Chamberlain
The hard work being done by the industry to prove its commitment to patients and better health is being hampered by its reputation of unreliability
|
October 15, 2007
By:
Heather Frahm, Catalyst
The ability to review what people are saying about a brand has become a hot topic among pharmaceutical marketers. Managing a brand used to be fairly straightforward, until, of course, the advent of the Internet. Today, the challenge is enormous: blogs, podcasts, micro-blogging, instant messaging, Wikis....
|
October 15, 2007
By:
Vince Parry
A win-win marketing strategy that illuminates, educates, and promotes at the same
|
|
October 15, 2007
By:
Marylyn Donahue
The direct-to-consumer marketing campaign for havidol, a drug for dysphoric social attention consumption deficit anxiety disorder, is drawing lots of public reaction. (but neither the drug nor the disease is real.)
|
October 15, 2007
Lack of trust is preventing pharma from doing what it does better than any other entity on the globe: research and develop new cures and treatments, says Billy Tauzin, president of PhRMA. What to do about it? Twelve top brandmeisters weigh in.
|
October 15, 2007
By:
Marylyn Donahue
Sometimes looking back is a way to look forward
|
|
PharmExec Blog
Follow Us
RSS
Bookstore
